Skip to main content
. 2023 Jan 10;23:12. doi: 10.1186/s12905-022-02153-7

Table 1.

Comparisons of sociodemographic and disease-related characteristics among three QOL trajectory patterns (N = 124)

Characteristics Categories Total (N = 124) Consistently low QOL group (N = 27) Consistently moderate QOL group (N = 57) Consistently high QOL group (N = 40) χ2 or F P
N (%) or Mean ± SD N (%) or Mean ± SD N (%) or Mean ± SD N (%) or Mean ± SD
Age (years, range: 26–54) 48.75 ± 8.01 49.70 ± 6.63 49.37 ± 7.99 47.23 ± 8.82 1.09 0.340
 ~ 44 39 (31.5) 7 (5.6) 17 (13.7) 15 (12.1)
46 ~ 54 51 (41.1) 13 (10.5) 24 (19.4) 14 (11.3)
55 ~  34 (27.4) 7 (5.6) 16 (12.9) 11 (8.9)
Educational level  ≤ High school 72 (58.0) 16 (12.9) 37 (29.9) 19 (15.3) 2.95 0.229
 ≥ University 52 (42.0) 11 (8.9) 20 (16.1) 21 (16.9)
Spouse No 13 (10.5) 4 (3.2) 2 (1.6) 7 (5.6) 5.59 0.061
Yes 111 (89.5) 23 (18.6) 55 (44.4) 33 (26.6)
Religion No 67 (54.0) 11 (8.9) 33 (26.6) 23 (18.5) 2.46 0.293
Yes 57 (46.0) 16 (12.9) 24 (19.4) 17 (13.7)
Perceived economic status High 7 (5.6) 3 (2.4) 2 (1.6) 2 (1.6) 10.21 0.037
Middle 95 (76.6) 15 (12.1) 45 (36.3) 35 (28.2)
Low 22 (17.8) 9 (7.3) 10 (8.1) 3 (2.4)
Perceived economic burden None 28 (22.6) 4 (3.2) 6 (4.8) 18 (14.5) 20.33  < 0.001
Little 84 (67.7) 18 (14.5) 47 (37.9) 19 (15.3)
Severe 12 (9.7) 5 (4.0) 4 (3.2) 3 (2.4)
Employment status Unemployed 83 (66.9) 18 (14.5) 38 (30.6) 27 (21.8) 0.01 0.996
Employed 41 (33.1) 9 (7.3) 19 (15.3) 13 (10.5)
Stage of cancer 1 72 (58.1) 16 (12.9) 32 (25.8) 24 (19.4) 2.19 0.700
2 38 (30.6) 9 (7.3) 16 (12.9) 13 (10.5)
3 14 (11.3) 2 (1.6) 9 (7.3) 3 (2.4)
Type of surgery Partial mastectomy 96 (77.4) 22 (17.7) 42 (33.9) 32 (25.8) 0.86 0.650
Total mastectomy 28 (22.6) 5 (4.0) 15 (12.1) 8 (6.5)
Chemotherapy No 54 (43.5) 11 (8.9) 25 (20.2) 18 (14.5) 2.15 0.905
Yes 70 (56.5) 16 (12.9) 32 (25.8) 22 (17.7)
Radiotherapy No 11 (8.9) 3 (2.4) 6 (4.8) 2 (1.6) 1.10 0.576
Yes 113 (91.1) 24 (19.4) 51 (41.1) 38 (30.6)
Hormone therapy No 16 (12.9) 3 (2.4) 6 (4.8) 7 (5.6) 1.12 0.572
Yes 108 (87.1) 24 (19.4) 51 (41.1) 33 (26.6)
Target therapy No 104 (83.9) 22 (17.7) 52 (41.9) 30 (24.2) 4.72 0.094
Yes 20 (16.1) 5 (4.0) 5 (4.0) 10 (8.1)

N number, SD standard deviation, QOL quality of life